Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing Type
144
Filing Date
11/11/2025
Updated
11/12/25, 2:03 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities